Background: This study was conducted to investigate the
relationship between clinical course and pulmonary artery (PA) diameters
in children diagnosed with COVID-19. Method: The study included 62
patients who presented COVID-19 symptoms between March 2020 and April
2021. Group 1 consisted of 32 pediatric patients who were COVID-19 PCR
(+), while Group 2 consisted of 30 pediatric patients who were COVID-19
PCR(-). The data were collected retrospectively from medical records.
Patients who developed pneumonia due to causes other than COVID-19 and
those who had a history of pulmonary hypertension or pulmonary
thromboembolism were excluded. The patients were examined based on their
Computerized Tomographic (CT) findings, simultaneous whole blood
parameters and biochemical parameters. Results: The thoracic CT findings
of 18 of the patients in Group 1 were found normal. The CT images of 14
patients showed pulmonary involvement. Among the patients with pulmonary
involvement, 8 had moderate pneumonia characterized by a ground-glass
pattern, and 6 had severe pneumonia indicated by consolidation and
linear opacities. The right pulmonary artery, left pulmonary artery and
inferior vena cava (IVC) diameters of the patients in Group 1 were
significantly higher than those of the patients in Group 2. Conclusion:
The results of this study suggested that increased PA diameters in
children diagnosed with COVID-19 may be accompanied by increased
inflammation, high vascular resistance, hypoxemia and thromboembolic
events. While it is thought that increased PA and IVC diameters are a
factor that may indicate clinical deterioration in COVID-19 patients,
more comprehensive studies are needed.